Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease
John Marshall(Chapman University), Seng H. Cheng(Pfizer (United States))
Cited by 72
Related Papers
Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes
|Diabetes|2007|239
Single Subunits of the GABA <sub>A</sub> Receptor Form Ion Channels with Properties of the Native Receptor
|Science|1988|196
Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease
|Molecular Therapy|2009|169
Correction of the Nonlinear Dose Response Improves the Viability of Adenoviral Vectors for Gene Therapy of Fabry Disease
|Human Gene Therapy|2002|46
Correction: Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome
|PLoS Biology|2013|24